Clinical Trial Update: First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers. [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of a new antibody treatment for tick-borne encephalitis in healthy volunteers. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Snippet

Sponsor: Giuseppe Pantaleo | Conditions: The Tick-borne Encephalitis Virus (TBEV) | Phase 1 | Status: NOT_YET_RECRUITING